Ubillos I, Aguilar R, Sanz H, Jimenez A, Vidal M, Valmaseda A
PLoS One. 2018; 13(7):e0199278.
PMID: 29966018
PMC: 6028107.
DOI: 10.1371/journal.pone.0199278.
Ubillos I, Jimenez A, Vidal M, Bowyer P, Gaur D, Dutta S
Malar J. 2018; 17(1):219.
PMID: 29859096
PMC: 5984756.
DOI: 10.1186/s12936-018-2369-3.
Ubillos I, Campo J, Jimenez A, Dobano C
Malar J. 2018; 17(1):216.
PMID: 29843713
PMC: 5975539.
DOI: 10.1186/s12936-018-2365-7.
Long C, Zavala F
Cold Spring Harb Perspect Med. 2017; 7(8.
PMID: 28389518
PMC: 5538407.
DOI: 10.1101/cshperspect.a025577.
Stone B, Kas A, Billman Z, Fuller D, Fuller J, Shendure J
PLoS One. 2016; 11(4):e0153449.
PMID: 27070430
PMC: 4829254.
DOI: 10.1371/journal.pone.0153449.
Discovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine Development.
Aguiar J, Bolton J, Wanga J, Sacci J, Iriko H, Mazeika J
PLoS One. 2015; 10(8):e0136109.
PMID: 26292257
PMC: 4546230.
DOI: 10.1371/journal.pone.0136109.
Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection.
Obiero J, Shekalaghe S, Hermsen C, Mpina M, Bijker E, Roestenberg M
Infect Immun. 2015; 83(5):2185-96.
PMID: 25776749
PMC: 4399069.
DOI: 10.1128/IAI.03069-14.
Measuring naturally acquired ex vivo IFN-γ responses to Plasmodium falciparum cell-traversal protein for ookinetes and sporozoites (CelTOS) in Ghanaian adults.
Anum D, Kusi K, Ganeshan H, Hollingdale M, Ofori M, Koram K
Malar J. 2015; 14:20.
PMID: 25604473
PMC: 4308902.
DOI: 10.1186/s12936-014-0539-5.
Clinical trial in healthy malaria-naïve adults to evaluate the safety, tolerability, immunogenicity and efficacy of MuStDO5, a five-gene, sporozoite/hepatic stage Plasmodium falciparum DNA vaccine combined with escalating dose human GM-CSF DNA.
Richie T, Charoenvit Y, Wang R, Epstein J, Hedstrom R, Kumar S
Hum Vaccin Immunother. 2012; 8(11):1564-84.
PMID: 23151451
PMC: 3601132.
DOI: 10.4161/hv.22129.
Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites.
Mikolajczak S, Sacci Jr J, De La Vega P, Camargo N, VanBuskirk K, Krzych U
Cell Microbiol. 2011; 13(8):1250-60.
PMID: 21569184
PMC: 4155577.
DOI: 10.1111/j.1462-5822.2011.01617.x.
Plasmodium falciparum liver stage antigen-1 is cross-linked by tissue transglutaminase.
Nicoll W, Sacci J, Rodolfo C, Di Giacomo G, Piacentini M, Holland Z
Malar J. 2011; 10:14.
PMID: 21255444
PMC: 3037345.
DOI: 10.1186/1475-2875-10-14.
A prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarray.
Crompton P, Kayala M, Traore B, Kayentao K, Ongoiba A, Weiss G
Proc Natl Acad Sci U S A. 2010; 107(15):6958-63.
PMID: 20351286
PMC: 2872454.
DOI: 10.1073/pnas.1001323107.
Transcriptionally active PCR for antigen identification and vaccine development: in vitro genome-wide screening and in vivo immunogenicity.
Regis D, Dobano C, Quinones-Olson P, Liang X, Graber N, Stefaniak M
Mol Biochem Parasitol. 2008; 158(1):32-45.
PMID: 18164079
PMC: 2699467.
DOI: 10.1016/j.molbiopara.2007.11.009.
Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization.
Jiang G, Charoenvit Y, Moreno A, Baraceros M, Banania G, Richie N
Malar J. 2007; 6:135.
PMID: 17925026
PMC: 2147027.
DOI: 10.1186/1475-2875-6-135.
Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design.
Garcia J, Puentes A, Patarroyo M
Clin Microbiol Rev. 2006; 19(4):686-707.
PMID: 17041140
PMC: 1592691.
DOI: 10.1128/CMR.00063-05.
Process development and analysis of liver-stage antigen 1, a preerythrocyte-stage protein-based vaccine for Plasmodium falciparum.
Hillier C, Ware L, Barbosa A, Angov E, Lyon J, Heppner D
Infect Immun. 2005; 73(4):2109-15.
PMID: 15784552
PMC: 1087442.
DOI: 10.1128/IAI.73.4.2109-2115.2005.
Immunity to liver stage malaria: considerations for vaccine design.
Taylor-Robinson A
Immunol Res. 2003; 27(1):53-70.
PMID: 12637768
DOI: 10.1385/IR:27:1:53.
Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.
Joshi M, Gam A, Boykins R, Kumar S, Sacci J, Hoffman S
Infect Immun. 2001; 69(8):4884-90.
PMID: 11447164
PMC: 98578.
DOI: 10.1128/IAI.69.8.4884-4890.2001.
Cytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya.
John C, Sumba P, Ouma J, Nahlen B, King C, Kazura J
Infect Immun. 2000; 68(9):5198-204.
PMID: 10948144
PMC: 101778.
DOI: 10.1128/IAI.68.9.5198-5204.2000.
Analysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India.
Joshi S, Bharadwaj A, Chatterjee S, Chauhan V
Infect Immun. 1999; 68(1):141-50.
PMID: 10603380
PMC: 97113.
DOI: 10.1128/IAI.68.1.141-150.2000.
